Results 91 to 100 of about 709,989 (248)

Diagnostic antibodies at an inflection point: From discovery platforms to design‐oriented engineering

open access: yesVIEW, EarlyView.
This study systematically organizes the evolution of diagnostic antibodies from discovery platforms to design‐oriented engineering and analyzes the strengths and limitations of each approach. Meanwhile, it provides a critical, literature‐driven synthesis of current challenges, proposing integrated strategies for assay‐aware and function‐driven antibody
Qitao Song   +14 more
wiley   +1 more source

Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery

open access: yesVIEW, EarlyView.
This study provides a comprehensive and up‐to‐date analysis of recent progress in HMN technology, covering fundamental transdermal delivery mechanisms and design principles, biomaterials used in HMN fabrication, drug loading and release strategies, and emerging therapeutic applications.
Mohammad Muhtasim Ittisaf   +5 more
wiley   +1 more source

Real-world data and clinical management experience in passive immunization for respiratory syncytial virus prevention in children

open access: yesVaccine: X
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in children under 5 years of age worldwide. Currently, there are no approved curative treatments, and clinical management remains primarily focused on ...
Yongping Xie   +3 more
doaj   +1 more source

Active and passive immunization for cancer [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2014
Vaccination started around the 10th century AD as a means of preventing smallpox. By the end of the 19th century such therapeutic vaccines were well established with both active and passive preparations being used in clinical practice. Active immunization involved administering an immunogen that might be live/ attenuated, killed/ inactivated, toxoid or
openaire   +2 more sources

Vaccine Hunting: Balancing Strategic Independence, Cooperation and Multilateral Obligations in Scandinavian COVID‐19 Vaccine Diplomacy

open access: yesGlobal Policy, EarlyView.
ABSTRACT How do states navigate the balance between multilateral obligations, bilateral cooperation and strategic independence during global crises? This article provides an in‐depth empirical analysis of the diplomatic efforts deployed by Denmark and Norway to secure vaccine access during the COVID‐19 pandemic.
Antoine de Bengy Puyvallée   +2 more
wiley   +1 more source

A real-world based study for immunogenicity and safety for three immunization schedules of polio vaccine

open access: yesScientific Reports
To evaluate the immunogencity and safety for three immunization schedules of inactivated poliovirus vaccine (IPV) and bivalent oral poliovirus vaccine (bOPV) for providing a basis for further optimization of the polio sequential immunization schedule. To
Li Sun   +11 more
doaj   +1 more source

Immunization strategies for health care practices and providers [PDF]

open access: yes
This online series of 15 webinars provides an overview of the principles of vaccination, general recommendations, immunization strategies for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent them.

core  

Significant Far‐Right Challenges to Australian Society? The XYZ and AustraliaOne

open access: yesAustralian Journal of Politics &History, EarlyView.
ABSTRACT Scholars who analyse the Australian far‐right from a criminological or security studies perspective propose that activists and groups pose ‘political’ challenges to Australian society. This paper examines the far‐right news website The XYZ and the AustraliaOne political party, and argues that claims that the far‐right may normalise ...
Timothy Lynch
wiley   +1 more source

General best practice guidelines for immunization, Part 1 [PDF]

open access: yes
This online series of 15 webinars provides an overview of the principles of vaccination, general recommendations, immunization strategies for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent them.

core  

Pre‐Seasonal Treatment With Recombinant Carrier‐Based Birch Vaccine Improves Birch Pollen Allergy

open access: yesAllergy, EarlyView.
We conducted a two stage SCIT trial with GNR‐127 containing a recombinant fusion protein consisting of Bet v 1 and Mal d 1‐derived peptides fused to PreS from HBV. Stage 1 identified two safe maximum tolerated doses (40 μg and 80 μg). In the following Stage 2, five preseasonal injections were well tolerated, induced dose‐dependent allergen‐specific IgG,
Musa R. Khaitov   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy